In a release, the FDA said repetitive use of a nasal spray containing a gram-negative pathogen can potentially lead to colonization and subsequent infection which can be life threatening in certain patient populations, such as those with cystic fibrosis or immuno-compromised.

On August 28, Product Quest expanded the recall to include all lots of nasal products and baby oral gels currently within expiration that were manufactured at the company’s Florida facility.

The FDA put out this updated LIST and said the products can be identified by checking the item code, product description, lot number, and expiration date.